Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine

Vaccine

Volumn 22, Issue 27-28, 2004, Pages 3722-3726

  Beasley, David W C ^a   Li, Li ^a   Suderman, Miguel T ^a   Guirakhoo, Farshad ^b   Trent, Dennis W ^b   Monath, Thomas P ^b   Shope, Robert E ^a   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Acambis   (United States)

Author keywords

ChimeriVax JE; Genotype; Japanese encephalitis virus

Indexed keywords

CHIMERIVAX; JAPANESE ENCEPHALITIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GENOTYPE; INFECTION PREVENTION; JAPANESE ENCEPHALITIS VIRUS; LETHAL DOSE; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; PROTECTION; VIRUS INFECTION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ANIMALS; ANTIBODIES, VIRAL; ENCEPHALITIS VIRUS, JAPANESE; ENCEPHALITIS, JAPANESE; GENOTYPE; IMMUNIZATION, PASSIVE; JAPANESE ENCEPHALITIS VACCINES; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; NEUTRALIZATION TESTS; RECOMBINANT FUSION PROTEINS; SURVIVAL ANALYSIS;

EID: 4143125552     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.03.027     Document Type: Article

References (22)

1. Tsai T.F. New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998. Vaccine. 18(Suppl 2):2000;1-25
2. Uchil P.D., Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am. J. Trop. Med. Hyg. 165(3):2001;242-251
3. Solomon T., Ni H., Beasley D.W., Ekkelenkamp M., Cardosa M.J., Barrett A.D. Origin and evolution of Japanese encephalitis virus in southeast Asia. J. Virol. 77(5):2003;3091-3098
4. Wills M.R., Singh B.K., Debnath N.C., Barrett A.D. Immunogenicity of wild-type and vaccine strains of Japanese encephalitis virus and the effect of haplotype restriction on murine immune responses. Vaccine. 11(7):1993;761-766
5. Ali A., Igarashi A. Antigenic and genetic variations among Japanese encephalitis virus strains belonging to genotype 1. Microbiol. Immunol. 41(3):1997;241-252
6. Markoff L. Points to consider in the development of a surrogate for efficacy of novel Japanese encephalitis virus vaccines. Vaccine. 18(Suppl 2):2000;26-32
7. Tsarev S.A., Sanders M.L., Vaughn D.W., Innis B.L. Phylogenetic analysis suggests only one serotype of Japanese encephalitis virus. Vaccine. 18(Suppl 2):2000;36-43
8. Monath T.P. Japanese encephalitis vaccines: current vaccines and future prospects. Curr. Top. Microbiol. Immunol. 267:2002;105-138
9. Hoke C.H., Nisalak A., Sangawhipa N., Jatanasen S., Laorakapongse T., Innis B.L., et al. Protection against Japanese encephalitis by inactivated vaccines. N. Engl. J. Med. 319(10):1988;608-614
10. Monath T.P., McCarthy K., Bedford P., Johnson C.T., Nichols R., Yoksan S., et al. Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections. Vaccine. 20(7/8):2002;1004- 1018
11. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:1938;493-497
12. WHO Expert Committee on Biological Standardization. Thirty-eighth report. World Health Organ Tech Rep Ser 1988;771:1-221.
13. Ni H., Barrett A.D. Molecular differences between wild-type Japanese encephalitis virus strains of high and low mouse neuroinvasiveness. J. Gen. Virol. 77(Pt 7):1996;1449-1455
14. Konishi E., Ajiro N., Nukuzuma C., Mason P.W., Kurane I. Comparison of protective efficacies of plasmid DNAs encoding Japanese encephalitis virus proteins that induce neutralizing antibody or cytotoxic T lymphocytes in mice. Vaccine. 21(25/26):2003;3675-3683
15. Jia L., Wang Z., Yu Y. Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses. Chin Med. J. (Engl.). 116(6):2003;941-943
16. Wu C.J., Huang H.W., Tao M.H. Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. Vaccine. 21(25/26):2003;3938-3945
17. Srivastava A.K., Putnak J.R., Lee S.H., Hong S.P., Moon S.B., Barvir D.A., et al. A purified inactivated Japanese encephalitis virus vaccine made in Vero cells. Vaccine. 19(31):2001;4557-4565
18. Broom A.K., Wallace M.J., Mackenzie J.S., Smith D.W., Hall R.A. Immunisation with gamma globulin to Murray valley encephalitis virus and with an inactivated Japanese encephalitis virus vaccine as prophylaxis against Australian encephalitis: evaluation in a mouse model. J. Med. Virol. 61(2):2000;259-265
19. Wallace M.J., Smith D.W., Broom A.K., Mackenzie J.S., Hall R.A., Shellam G.R., et al. Antibody-dependent enhancement of Murray Valley encephalitis virus virulence in mice. J. Gen. Virol. 84(7):2003;1723-1728
20. Lobigs M., Pavy M., Hall R. Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex. Vaccine. 21(15):2003;1572-1579
21. Gould E.A., Buckley A., Barrett A.D., Cammack N. Neutralizing (54 K) and non-neutralizing (54 K and 48 K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J. Gen. Virol. 67(Pt 3):1986;591-595
22. Ma S.P., Yoshida Y., Makino Y., Tadano M., Ono T., Ogawa M. Short report: a major genotype of Japanese encephalitis virus currently circulating in Japan. Am. J. Trop. Med. Hyg. 69(2):2003;151-154